Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Short-term Investments (2023 - 2025)

GeneDx Holdings has reported Short-term Investments over the past 3 years, most recently at $66.3 million for Q4 2025.

  • Quarterly results put Short-term Investments at $66.3 million for Q4 2025, up 18.42% from a year ago — trailing twelve months through Dec 2025 was $66.3 million (up 18.42% YoY), and the annual figure for FY2025 was $66.3 million, up 18.42%.
  • Short-term Investments for Q4 2025 was $66.3 million at GeneDx Holdings, up from $59.1 million in the prior quarter.
  • Over the last five years, Short-term Investments for WGSWW hit a ceiling of $66.3 million in Q4 2025 and a floor of $12.1 million in Q1 2023.
  • Median Short-term Investments over the past 3 years was $56.0 million (2024), compared with a mean of $46.3 million.
  • Biggest five-year swings in Short-term Investments: surged 140.77% in 2024 and later grew 0.93% in 2025.
  • GeneDx Holdings' Short-term Investments stood at $30.5 million in 2023, then skyrocketed by 83.72% to $56.0 million in 2024, then rose by 18.42% to $66.3 million in 2025.
  • The last three reported values for Short-term Investments were $66.3 million (Q4 2025), $59.1 million (Q3 2025), and $60.4 million (Q2 2025) per Business Quant data.